Novozymes strengthens and accelerates its BioHealth-business by acquiring a majority stake in Synergia Life Sciences, a leading developer and manufacturer of probiotics and vitamin K2-7 Novozymes acquires a majority stake in Synergia Life Sciences Pte. Ltd., a leading player in the field of spore probiotics and vitamin K2-7, for a cash payment of DKK ~1 billion (USD ~150 million)....

Novozymes is unlocking growth by delivering strong Q3 results and increasing full-year guidance Novozymes delivered 7% organic sales growth in the third quarter and 6% organic sales growth in the first nine months of 2021. Due to stronger performance the company has upgraded its full-year...

Novozymes is unlocking growth with the ambition of doubling company revenue by 2030 With the launch of “Unlocking Growth – Powered by Biotech” Novozymes presents its 2025-strategy. It sets out an organic sales growth target of 5+% CAGR for the 5-year period until 2025, coupled with...

Novozymes is combining cutting-edge science and business expertise to help feed the world sustainably To feed a growing population, Novozymes is inviting all interested parties to help co-create and innovate the future of sustainable protein. By combining science with business expertise Novozymes...